Date Title  
Aug 04, 2022
Summary ToggleSol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
 
Jun 02, 2022
Summary ToggleGalderma Launches EPSOLAY® Cream, a Medical Advance to Treat Bumps and Blemishes of Rosacea
 
Jun 01, 2022
Summary ToggleSol-Gel Technologies to Participate in the 2022 Jefferies Global Healthcare Conference
 
May 17, 2022
Summary ToggleSol-Gel Technologies to Present in Upcoming H.C. Wainwright Global Investment Conference
 
May 13, 2022
Summary ToggleSol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update
 
Apr 25, 2022
Summary ToggleSol-Gel Technologies and Galderma Announce FDA Approval of EPSOLAY®
 
Apr 14, 2022
Summary ToggleSol-Gel Technologies Announces the Commercial Availability of TWYNEO®
 
Mar 30, 2022
Summary ToggleSol-Gel Technologies Reports Full Year 2021 Financial Results and Corporate Developments
 
Mar 25, 2022
Summary ToggleSol-Gel Technologies Announces U.S. Commercial Partner Galderma to Promote TWYNEO® at the American Academy of Dermatology Annual Meeting to be Held March 25-29 in Boston, MA
 
Dec 22, 2021
Summary ToggleSol-Gel Technologies to Participate in Upcoming LifeSci Partners Corporate Access Event and H.C. Wainwright BioConnect 2022 Healthcare Conference
 
Displaying 1 - 10 of 89 results